Pilot trial of Aspirin versus Ticagrelor in Congestive Heart Failure

Trial Profile

Pilot trial of Aspirin versus Ticagrelor in Congestive Heart Failure

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 24 Jun 2016

At a glance

  • Drugs Ticagrelor (Primary) ; Aspirin
  • Indications Embolism and thrombosis; Heart failure
  • Focus Biomarker; Pharmacodynamics
  • Acronyms PATCH
  • Most Recent Events

    • 08 Jun 2016 Status changed from discontinued to withdrawn prior to enrolment.
    • 08 Sep 2014 Status changed from not yet recruiting to discontinued as reported by Australian New Zealand Clinical Trials Registry record.
    • 23 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top